Global Human Microbiome Therapeutics Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	220 Pages	TechNavio	May, 2025	INF20016791

Best Price Guarantee
Price	from $2,500
Length	220 Pages
Publisher	TechNavio
Published Date	May, 2025
SKU	INF20016791

Human Microbiome Therapeutics Market 2025-2029

The human microbiome therapeutics market is forecasted to grow by USD 2361.4 mn during 2024-2029, accelerating at a CAGR of 44% during the forecast period. The report on the human microbiome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, robust pipeline in human microbiome therapeutics market, and side effects of existing treatments for heath disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's human microbiome therapeutics market is segmented as below:

By Product

Probiotics
Prebiotics
Medical foods
Prescription drugs

By Application

Gastrointestinal disorders
Infectious diseases
Others

By Route Of Administration

Oral
Rectal (FMT)
Injectable
Topical

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in industry-academia collaboration for development of novel therapeutics as one of the prime reasons driving the human microbiome therapeutics market growth during the next few years. Also, increasing investments in human microbiome therapeutics and increasing partnerships in human microbiome therapeutics market will lead to sizable demand in the market.

The report on the human microbiome therapeutics market covers the following areas:

Human Microbiome Therapeutics Market sizing
Human Microbiome Therapeutics Market forecast
Human Microbiome Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human microbiome therapeutics market vendors that include BiomX Inc., Eligo Bioscience, ENTEROME SA, Evogene Ltd., Ferring BV, Finch Therapeutics Group Inc., Flightpath Biosciences, Johnson and Johnson Services Inc., Locus Biosciences Inc., MaaT Pharma, Microbiotica Ltd., OptiBiotix Health Plc, Osel Inc., PureTech Health Plc, Second Genome Therapeutics, Seres Therapeutics Inc., Synlogic Inc., Takeda Pharmaceutical Co. Ltd., Vedanta Biosciences Inc., and YSOPIA Bioscience. Also, the human microbiome therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Human Microbiome Therapeutics Market 2019 - 2023; Historic Market Size - Data Table on Global Human Microbiome Therapeutics Market 2019 - 2023 ($ million); 5.2 Product segment analysis 2019 - 2023; Historic Market Size - Product Segment 2019 - 2023 ($ million); 5.3 Application segment analysis 2019 - 2023; Historic Market Size - Application Segment 2019 - 2023 ($ million); 5.4 Route of Administration segment analysis 2019 - 2023; Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); 5.5 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.6 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 The AI impact on Global Human Microbiomes Therapeutics Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product: 8.1 Market segments; Chart on Product - Market share 2024-2029 (%); Data Table on Product - Market share 2024-2029 (%); 8.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 8.3 Probiotics - Market size and forecast 2024-2029; Chart on Probiotics - Market size and forecast 2024-2029 ($ million); Data Table on Probiotics - Market size and forecast 2024-2029 ($ million); Chart on Probiotics - Year-over-year growth 2024-2029 (%); Data Table on Probiotics - Year-over-year growth 2024-2029 (%); 8.4 Prebiotics - Market size and forecast 2024-2029; Chart on Prebiotics - Market size and forecast 2024-2029 ($ million); Data Table on Prebiotics - Market size and forecast 2024-2029 ($ million); Chart on Prebiotics - Year-over-year growth 2024-2029 (%); Data Table on Prebiotics - Year-over-year growth 2024-2029 (%); 8.5 Medical foods - Market size and forecast 2024-2029; Chart on Medical foods - Market size and forecast 2024-2029 ($ million); Data Table on Medical foods - Market size and forecast 2024-2029 ($ million); Chart on Medical foods - Year-over-year growth 2024-2029 (%); Data Table on Medical foods - Year-over-year growth 2024-2029 (%); 8.6 Prescription drugs - Market size and forecast 2024-2029; Chart on Prescription drugs - Market size and forecast 2024-2029 ($ million); Data Table on Prescription drugs - Market size and forecast 2024-2029 ($ million); Chart on Prescription drugs - Year-over-year growth 2024-2029 (%); Data Table on Prescription drugs - Year-over-year growth 2024-2029 (%); 8.7 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Application: 9.1 Market segments; Chart on Application - Market share 2024-2029 (%); Data Table on Application - Market share 2024-2029 (%); 9.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 9.3 Gastrointestinal disorders - Market size and forecast 2024-2029; Chart on Gastrointestinal disorders - Market size and forecast 2024-2029 ($ million); Data Table on Gastrointestinal disorders - Market size and forecast 2024-2029 ($ million); Chart on Gastrointestinal disorders - Year-over-year growth 2024-2029 (%); Data Table on Gastrointestinal disorders - Year-over-year growth 2024-2029 (%); 9.4 Infectious diseases - Market size and forecast 2024-2029; Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million); Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million); Chart on Infectious diseases - Year-over-year growth 2024-2029 (%); Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%); 9.5 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.6 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by Route of Administration: 10.1 Market segments; Chart on Route of Administration - Market share 2024-2029 (%); Data Table on Route of Administration - Market share 2024-2029 (%); 10.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 10.3 Oral - Market size and forecast 2024-2029; Chart on Oral - Market size and forecast 2024-2029 ($ million); Data Table on Oral - Market size and forecast 2024-2029 ($ million); Chart on Oral - Year-over-year growth 2024-2029 (%); Data Table on Oral - Year-over-year growth 2024-2029 (%); 10.4 Rectal (FMT) - Market size and forecast 2024-2029; Chart on Rectal (FMT) - Market size and forecast 2024-2029 ($ million); Data Table on Rectal (FMT) - Market size and forecast 2024-2029 ($ million); Chart on Rectal (FMT) - Year-over-year growth 2024-2029 (%); Data Table on Rectal (FMT) - Year-over-year growth 2024-2029 (%); 10.5 Injectable - Market size and forecast 2024-2029; Chart on Injectable - Market size and forecast 2024-2029 ($ million); Data Table on Injectable - Market size and forecast 2024-2029 ($ million); Chart on Injectable - Year-over-year growth 2024-2029 (%); Data Table on Injectable - Year-over-year growth 2024-2029 (%); 10.6 Topical - Market size and forecast 2024-2029; Chart on Topical - Market size and forecast 2024-2029 ($ million); Data Table on Topical - Market size and forecast 2024-2029 ($ million); Chart on Topical - Year-over-year growth 2024-2029 (%); Data Table on Topical - Year-over-year growth 2024-2029 (%); 10.7 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ million); Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape: 12.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 12.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 12.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 12.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 12.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 12.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 12.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 12.8 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 12.9 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 12.10 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 12.11 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 12.12 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 12.13 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ million); Data Table on Italy - Market size and forecast 2024-2029 ($ million); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 12.14 Spain - Market size and forecast 2024-2029; Chart on Spain - Market size and forecast 2024-2029 ($ million); Data Table on Spain - Market size and forecast 2024-2029 ($ million); Chart on Spain - Year-over-year growth 2024-2029 (%); Data Table on Spain - Year-over-year growth 2024-2029 (%); 12.15 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 12.16 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 12.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints: 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 BiomX Inc.; BiomX Inc. - Overview; BiomX Inc. - Product / Service; BiomX Inc. - Key offerings; SWOT; 15.5 Eligo Bioscience; Eligo Bioscience - Overview; Eligo Bioscience - Product / Service; Eligo Bioscience - Key offerings; SWOT; 15.6 ENTEROME SA; ENTEROME SA - Overview; ENTEROME SA - Product / Service; ENTEROME SA - Key offerings; SWOT; 15.7 Evogene Ltd.; Evogene Ltd. - Overview; Evogene Ltd. - Business segments; Evogene Ltd. - Key offerings; Evogene Ltd. - Segment focus; SWOT; 15.8 Ferring BV; Ferring BV - Overview; Ferring BV - Product / Service; Ferring BV - Key news; Ferring BV - Key offerings; SWOT; 15.9 Finch Therapeutics Group Inc.; Finch Therapeutics Group Inc. - Overview; Finch Therapeutics Group Inc. - Product / Service; Finch Therapeutics Group Inc. - Key offerings; SWOT; 15.10 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; SWOT; 15.11 OptiBiotix Health Plc; OptiBiotix Health Plc - Overview; OptiBiotix Health Plc - Product / Service; OptiBiotix Health Plc - Key offerings; SWOT; 15.12 Osel Inc.; Osel Inc. - Overview; Osel Inc. - Product / Service; Osel Inc. - Key offerings; SWOT; 15.13 PureTech Health Plc; PureTech Health Plc - Overview; PureTech Health Plc - Business segments; PureTech Health Plc - Key offerings; PureTech Health Plc - Segment focus; SWOT; 15.14 Second Genome Therapeutics; Second Genome Therapeutics - Overview; Second Genome Therapeutics - Product / Service; Second Genome Therapeutics - Key offerings; SWOT; 15.15 Seres Therapeutics Inc.; Seres Therapeutics Inc. - Overview; Seres Therapeutics Inc. - Product / Service; Seres Therapeutics Inc. - Key offerings; SWOT; 15.16 Synlogic Inc.; Synlogic Inc. - Overview; Synlogic Inc. - Product / Service; Synlogic Inc. - Key offerings; SWOT; 15.17 Takeda Pharmaceutical Co. Ltd.; Takeda Pharmaceutical Co. Ltd. - Overview; Takeda Pharmaceutical Co. Ltd. - Product / Service; Takeda Pharmaceutical Co. Ltd. - Key news; Takeda Pharmaceutical Co. Ltd. - Key offerings; SWOT; 15.18 Vedanta Biosciences Inc.; Vedanta Biosciences Inc. - Overview; Vedanta Biosciences Inc. - Product / Service; Vedanta Biosciences Inc. - Key offerings; SWOT
16 Appendix: 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits8: Executive Summary - Chart on Incremental Growth; Exhibits9: Executive Summary - Data Table on Incremental Growth; Exhibits10: Executive Summary - Chart on Company Market Positioning; Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits12: Overview on criticality of inputs and factors of differentiation; Exhibits13: Overview on factors of disruption; Exhibits14: Impact of drivers and challenges in 2024 and 2029; Exhibits15: Parent Market; Exhibits16: Data Table on - Parent Market; Exhibits17: Market characteristics analysis; Exhibits18: Value chain analysis; Exhibits19: Offerings of companies included in the market definition; Exhibits20: Market segments; Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Historic Market Size - Data Table on Global Human Microbiome Therapeutics Market 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Product Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Application Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits31: Five forces analysis - Comparison between 2024 and 2029; Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits37: Chart on Market condition - Five forces 2024 and 2029; Exhibits38: Chart on Product - Market share 2024-2029 (%); Exhibits39: Data Table on Product - Market share 2024-2029 (%); Exhibits40: Chart on Comparison by Product; Exhibits41: Data Table on Comparison by Product; Exhibits42: Chart on Probiotics - Market size and forecast 2024-2029 ($ million); Exhibits43: Data Table on Probiotics - Market size and forecast 2024-2029 ($ million); Exhibits44: Chart on Probiotics - Year-over-year growth 2024-2029 (%); Exhibits45: Data Table on Probiotics - Year-over-year growth 2024-2029 (%); Exhibits46: Chart on Prebiotics - Market size and forecast 2024-2029 ($ million); Exhibits47: Data Table on Prebiotics - Market size and forecast 2024-2029 ($ million); Exhibits48: Chart on Prebiotics - Year-over-year growth 2024-2029 (%); Exhibits49: Data Table on Prebiotics - Year-over-year growth 2024-2029 (%); Exhibits50: Chart on Medical foods - Market size and forecast 2024-2029 ($ million); Exhibits51: Data Table on Medical foods - Market size and forecast 2024-2029 ($ million); Exhibits52: Chart on Medical foods - Year-over-year growth 2024-2029 (%); Exhibits53: Data Table on Medical foods - Year-over-year growth 2024-2029 (%); Exhibits54: Chart on Prescription drugs - Market size and forecast 2024-2029 ($ million); Exhibits55: Data Table on Prescription drugs - Market size and forecast 2024-2029 ($ million); Exhibits56: Chart on Prescription drugs - Year-over-year growth 2024-2029 (%); Exhibits57: Data Table on Prescription drugs - Year-over-year growth 2024-2029 (%); Exhibits58: Market opportunity by Product ($ million); Exhibits59: Data Table on Market opportunity by Product ($ million); Exhibits60: Chart on Application - Market share 2024-2029 (%); Exhibits61: Data Table on Application - Market share 2024-2029 (%); Exhibits62: Chart on Comparison by Application; Exhibits63: Data Table on Comparison by Application; Exhibits64: Chart on Gastrointestinal disorders - Market size and forecast 2024-2029 ($ million); Exhibits65: Data Table on Gastrointestinal disorders - Market size and forecast 2024-2029 ($ million); Exhibits66: Chart on Gastrointestinal disorders - Year-over-year growth 2024-2029 (%); Exhibits67: Data Table on Gastrointestinal disorders - Year-over-year growth 2024-2029 (%); Exhibits68: Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million); Exhibits69: Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million); Exhibits70: Chart on Infectious diseases - Year-over-year growth 2024-2029 (%); Exhibits71: Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%); Exhibits72: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits73: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits74: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits75: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits76: Market opportunity by Application ($ million); Exhibits77: Data Table on Market opportunity by Application ($ million); Exhibits78: Chart on Route of Administration - Market share 2024-2029 (%); Exhibits79: Data Table on Route of Administration - Market share 2024-2029 (%); Exhibits80: Chart on Comparison by Route of Administration; Exhibits81: Data Table on Comparison by Route of Administration; Exhibits82: Chart on Oral - Market size and forecast 2024-2029 ($ million); Exhibits83: Data Table on Oral - Market size and forecast 2024-2029 ($ million); Exhibits84: Chart on Oral - Year-over-year growth 2024-2029 (%); Exhibits85: Data Table on Oral - Year-over-year growth 2024-2029 (%); Exhibits86: Chart on Rectal (FMT) - Market size and forecast 2024-2029 ($ million); Exhibits87: Data Table on Rectal (FMT) - Market size and forecast 2024-2029 ($ million); Exhibits88: Chart on Rectal (FMT) - Year-over-year growth 2024-2029 (%); Exhibits89: Data Table on Rectal (FMT) - Year-over-year growth 2024-2029 (%); Exhibits90: Chart on Injectable - Market size and forecast 2024-2029 ($ million); Exhibits91: Data Table on Injectable - Market size and forecast 2024-2029 ($ million); Exhibits92: Chart on Injectable - Year-over-year growth 2024-2029 (%); Exhibits93: Data Table on Injectable - Year-over-year growth 2024-2029 (%); Exhibits94: Chart on Topical - Market size and forecast 2024-2029 ($ million); Exhibits95: Data Table on Topical - Market size and forecast 2024-2029 ($ million); Exhibits96: Chart on Topical - Year-over-year growth 2024-2029 (%); Exhibits97: Data Table on Topical - Year-over-year growth 2024-2029 (%); Exhibits98: Market opportunity by Route of Administration ($ million); Exhibits99: Data Table on Market opportunity by Route of Administration ($ million); Exhibits100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits101: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits102: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits103: Chart on Geographic comparison; Exhibits104: Data Table on Geographic comparison; Exhibits105: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on France - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on France - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ million); Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ million); Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on Japan - Market size and forecast 2024-2029 ($ million); Exhibits138: Data Table on Japan - Market size and forecast 2024-2029 ($ million); Exhibits139: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits142: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits143: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits145: Chart on Italy - Market size and forecast 2024-2029 ($ million); Exhibits146: Data Table on Italy - Market size and forecast 2024-2029 ($ million); Exhibits147: Chart on Italy - Year-over-year growth 2024-2029 (%); Exhibits148: Data Table on Italy - Year-over-year growth 2024-2029 (%); Exhibits149: Chart on Spain - Market size and forecast 2024-2029 ($ million)